By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Small Business Innovation Research (SBIR) 

Regional Area      U.S.A.
Phone: 800-382-4634 Fax: 800-462-4128


Company News
Meridian Life Science Awarded SBIR II By CDC To Develop Rotavirus Vaccine 12/2/2014 9:00:44 AM
Altor BioScience Corporation Initiates Clinical Development Of Its Novel IL-15 Super Agonist ALT-803 For Relapsed / Refractory Multiple Myeloma Supported By A Newly Awarded Phase 2 SBIR Grant From National Cancer Institute 11/4/2014 10:22:56 AM
OncoSec Medical Inc. Receives Phase 1 SBIR Funding For Development Of Novel Electroporation Technologies 10/27/2014 11:33:56 AM
Blaze Bioscience Inc. Announces National Cancer Institute SBIR Phase II Funding For Clinical Trial Of Tumor Paintâ„¢ BLZ-100 In Sarcoma 10/8/2014 10:10:04 AM
DiscoveryBioMed Awarded Dual SBIRAwards For Polycystic Kidney Disease (PKD) Drug Discovery, Validation, Optimization And Development 10/7/2014 10:16:30 AM
DecImmune Therapeutics Awarded $3 Million In SBIR Phase 2B Funding 10/3/2014 7:35:23 AM
Discovery Laboratories (DSCO) Receives SBIR Grant Valued Up To $3.0 Million To Support Development Of Aerosolized KL4 Surfactant To Address Radiation-Induced Lung Injury 10/1/2014 9:15:43 AM
Electrical Geodesics, Inc. Release: $1.7 Million Extension Of SBIR Grant From National Institute of Mental Health 9/25/2014 10:32:30 AM
Navidea Biopharmaceuticals (NAVB) Awarded $1.67M Fast Track National Institutes of Health (NIH) SBIR Grant For Evaluation Of Lymphoseekв In Cervical Cancer 9/23/2014 11:28:01 AM
ContraFect Corporation (CFRXU)'s Universal Influenza Treatment Receives SBIR Funding 9/17/2014 12:35:55 PM